GlassScriptPhysician profile
Britten W Williams
NPI 1538825443
$4,131.75
in general payments reported to CMS, 2019-2025
29 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.01 · 2022: $1,173 · 2023: $915 · 2024: $926 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,943.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,413.40 | 2022-2025 | Interstim, Altaviva, Nuro |
| Abbvie INC. | $355.64 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $302.09 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $186.50 | 2022-2024 | Myrbetriq, Veozah |
| Endo USA, INC. | $184.17 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $182.38 | 2022-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $180.54 | 2022-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $161.57 | 2022-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $157.33 | 2021-2025 | Myrisk, Prolaris |
| Urovant Sciences INC | $131.43 | 2022 | |
| Pfizer INC. | $122.12 | 2022-2025 | |
| Myovant Sciences INC. | $119.12 | 2022 | |
| Tolmar, INC. | $116.97 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $74.56 | 2023-2024 | Rezum Generator, Lithovue |
| Blue Earth Diagnostics | $65.62 | 2022-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.27 | 2022-2025 | Keytruda, Lynparza |
| Antares Pharma, INC. | $48.09 | 2022 | |
| Procept Biorobotics Corporation | $47.19 | 2022 | |
| Teleflex LLC | $45.86 | 2024 | Urolift |
| Axonics, INC. | $29.63 | 2022-2024 | Bulkamid |
| Abc Home Medical Supply, INC. | $21.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.38 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $19.02 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.80 | 2023 | Seglentis |
| Alnylam Pharmaceuticals INC. | $14.22 | 2025 | Oxlumo |
| Photocure INC | $13.48 | 2024 | Cysview |
| Angiodynamics, INC. | $13.16 | 2024 | Nanoknife |
| Halozyme INC | $13.14 | 2023 | |
| 180 Medical, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britten Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.